Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes

Journal of Autoimmunity
Devasenan DevendraEdwin Liu

Abstract

Mice have two insulin genes that differ in the insulin sequence by two amino acids, including the B9 position. Given prior studies of the B:9-23 insulin peptide in NOD mice, a fundamental question is whether the immune response to the B:9-23 peptide of the two insulins is identical. We investigate responses to the immunization with B:9-23 insulin 1 and 2 peptides in NOD and RIP-B7.1 Balb/c mice. NOD and F1 (Balb/c x C57/Bl6) B7.1 transgenic mice were given either B:9-23 insulin 1, B:9-23 insulin 2 or tetanus toxoid (TT) control peptide. Insulin autoantibodies (IAA), and anti-B:9-23 antibodies (IgG1 and IgG2c) were measured. Subcutaneous injection of the insulin 2 but not the insulin 1 peptide significantly protected NOD mice from diabetes. Conceptually similar, insulin 1 peptide immunization accelerated diabetes in the B7.1 mice compared with insulin 2 peptide. Insulin 1 and 2 peptides induced similar levels of IAA in the NOD mice except at week 26, where insulin 2 induced higher levels of IAA. Anti-IgG1 B:9-23 peptide antibodies were higher in the insulin 2 immunized group of NOD mice, while IgG2c anti-B:9-23 peptide antibodies were higher in the insulin 1 group. Adoptive transfer of splenocytes from insulin 1 immunized mice t...Continue Reading

References

May 26, 1995·Science·J D KatzD Mathis
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D Daniel, D R Wegmann
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·I AndréD Mathis
Apr 4, 1998·The Journal of Experimental Medicine·F SallustoA Lanzavecchia
Oct 20, 1998·Journal of Autoimmunity·V L HeathD W Mason
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·L YuG S Eisenbarth
Oct 21, 2000·Journal of Autoimmunity·D R Wegmann, G S Eisenbarth
Nov 7, 2001·The Journal of Clinical Investigation·C H KimE C Butcher
Jan 10, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Peter A Gottlieb, George S Eisenbarth
Apr 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hiroaki MoriyamaGeorge S Eisenbarth
Oct 9, 2002·The Journal of Clinical Investigation·Edwin LiuGeorge S Eisenbarth
Mar 18, 2003·The Journal of Clinical Investigation·Karine Thébault-BaumontChristian Boitard
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Scott M LiebermanTeresa P DiLorenzo
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hiroaki MoriyamaGeorge S Eisenbarth

❮ Previous
Next ❯

Citations

Jan 12, 2007·Gene Therapy·G J Prud'hommeQ Wang
Aug 22, 2012·Cold Spring Harbor Perspectives in Medicine·Peter ArvanChristopher J Rhodes
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Xavier Clemente-CasaresPere Santamaria
Apr 27, 2007·Diabetes Research and Clinical Practice·Hiroaki MoriyamaKoich Yokono
Mar 26, 2005·Immunological Reviews·Roberto Gianani, George S Eisenbarth
Sep 29, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Evie Melanitou
Feb 24, 2007·Molecular & Cellular Proteomics : MCP·Yannick BrunnerJean-Charles Sanchez
Nov 22, 2005·Clinical & Developmental Immunology·J M Jasinski, G S Eisenbarth
Jun 28, 2011·Endocrine Reviews·Vedran BrezarRoberto Mallone
Jul 26, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Adebowale AdebiyiJonathan H Jaggar
Apr 13, 2021·Frontiers in Immunology·Gaurang JhalaBalasubramanian Krishnamurthy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.